Comparative Effectiveness and Cost-Effectiveness of Generic Alendronate, Risendronate, Denosumab and Zolendronic Acid for Secondary Prevention of Fragility Fractures - Perliminay Results

To evaluate the relative health gains and costs of secondary prevention of fractures with generic alendronate, risedronate, denosumab and zoledronic acid.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: G Hagen Source Type: research